We are live on
!
Find out more
B
Braidwell Portfolio holdings
AUM
$3B
1-Year Est. Return
46.72%
This Fund
S&P 500
This Quarter
Est. Return
+4.56%
1 Year Est. Return
+46.72%
3 Year Est. Return
+56.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.72B
AUM Growth
-$442M
(-14%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-72.14%
Top 10 Holdings %
Top 10 Hldgs %
40.29%
Holding
93
New
5
Increased
13
Reduced
23
Closed
19
Top Buys
| 1 |
argenx
ARGX
|
+$71.4M |
| 2 |
Penumbra
PEN
|
+$28.2M |
| 3 |
TRML
Tourmaline Bio
TRML
|
+$18.1M |
| 4 |
Structure Therapeutics
GPCR
|
+$16.1M |
| 5 |
Lantheus
LNTH
|
+$14M |
Top Sells
| 1 |
Boston Scientific
BSX
|
+$61.5M |
| 2 |
Natera
NTRA
|
+$44.8M |
| 3 |
MRUS
Merus
MRUS
|
+$35.7M |
| 4 |
Intuitive Surgical
ISRG
|
+$33.6M |
| 5 |
Glaukos
GKOS
|
+$30.9M |
Sector Composition
| 1 | Healthcare | 48.6% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCPH
26
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $18.9M | 0.69% |
1,169,490
-2,166,731
| -65% | -$27.6M |
|
27
Repligen
RGEN
$8.35B
| $18.5M | 0.68% |
102,698
-15,702
| -13% | -$2.44M |
|
28
Mineralys Therapeutics
MLYS
$2.41B
| $17.4M | 0.64% |
2,023,900
| – | – |
|
29
Harrow
HROW
$1.6B
| $16.8M | 0.62% |
1,498,584
-310,100
| -17% | -$3.67M |
|
30
Amgen
AMGN
$193B
| $16.8M | 0.62% |
58,200
+22,000
| +61% | +$5.99M |
|
|
TERN
31
DELISTED
Terns Pharmaceuticals
TERN
| $15M | 0.55% |
2,318,050
-522,002
| -18% | -$2.76M |
|
|
THRD
32
DELISTED
Third Harmonic Bio
THRD
| $14.4M | 0.53% |
1,316,018
-337,973
| -20% | -$2.68M |
|
33
Outset Medical
OM
$84M
| $13M | 0.48% |
160,028
| – | – |
|
34
Cullinan Oncology
CGEM
$1.1B
| $12.6M | 0.46% |
1,240,865
-668,000
| -35% | -$5.92M |
|
|
35
Structure Therapeutics
GPCR
$3.53B
| $11.4M | 0.42% |
+280,158
| New | +$16.1M |
|
36
Spyre Therapeutics
SYRE
$8.86B
| $11.1M | 0.41% |
+515,000
| New | +$7.09M |
|
|
MRUS
37
DELISTED
Merus
MRUS
| $10.2M | 0.37% |
370,679
-1,530,658
| -81% | -$35.7M |
|
38
Dyne Therapeutics
DYN
$3.97B
| $10.1M | 0.37% |
755,811
-1,066,161
| -59% | -$10.4M |
|
39
Pulmonx
LUNG
$60.8M
| $10M | 0.37% |
787,954
-200,605
| -20% | -$2.09M |
|
40
Denali Therapeutics
DNLI
$3.65B
| $9.91M | 0.36% |
+461,769
| New | +$9.15M |
|
|
RAPT
41
DELISTED
RAPT Therapeutics
RAPT
| $9.67M | 0.36% |
48,663
-86,651
| -64% | -$10.7M |
|
42
Transmedics
TMDX
$2.61B
| $9.29M | 0.34% |
117,701
-189,499
| -62% | -$11.4M |
|
|
DBVT
43
DBV Technologies
DBVT
$930M
| $7.47M | 0.27% |
784,329
-426,450
| -35% | -$4.13M |
|
44
Viridian Therapeutics
VRDN
$2.1B
| $7.04M | 0.26% |
323,102
-1,412,080
| -81% | -$22.3M |
|
45
Adaptive Biotechnologies
ADPT
$916M
| $6.65M | 0.24% |
1,357,490
+389,800
| +40% | +$1.78M |
|
|
HLVX
46
DELISTED
HilleVax
HLVX
| $3.26M | 0.12% |
203,407
-1,245,839
| -86% | -$16.6M |
|
47
Compass Therapeutics
CMPX
$385M
| $496K | 0.02% |
317,761
-5,636,512
| -95% | -$9.75M |
|
|
AGEN
48
Agenus
AGEN
$209M
| – | – |
-315,352
| Closed | -$7.13M |
|
49
ALX Oncology
ALXO
$273M
| – | – |
-1,249,900
| Closed | -$6M |
|
50
AnaptysBio
ANAB
$1.65B
| – | – |
-1,049,823
| Closed | -$18.9M |
|
Similar funds
NC
VVP
SP
DIG
ECP
PCM
ROTUOC
SM